Anna D. Garrett, PharmD, BCPS, CPP

Articles by Anna D. Garrett, PharmD, BCPS, CPP

HEALTHY DIET MAY DECREASE RISK OF VTE

ByAnna D. Garrett, PharmD, BCPS, CPP

March 1st 2007

FISH OIL/WARFARIN COMBINATION MAY INCREASE BLEEDING RISK

ByAnna D. Garrett, PharmD, BCPS, CPP

March 1st 2007

AAICH RATE INCREASING

ByAnna D. Garrett, PharmD, BCPS, CPP

March 1st 2007

WARFARIN SENSITIVITY DNA TEST LAUNCHED

ByAnna D. Garrett, PharmD, BCPS, CPP

February 1st 2007

DOES ASPIRIN USE AFFECT ICH OUTCOME?

ByAnna D. Garrett, PharmD, BCPS, CPP

February 1st 2007

TEST HELPS PREDICT RISK OF RECURRENT VTE

ByAnna D. Garrett, PharmD, BCPS, CPP

February 1st 2007

PLAN NOW FOR DVT AWARENESS MONTH

ByAnna D. Garrett, PharmD, BCPS, CPP

February 1st 2007

DRUG-ELUTING STENTS MAY POSE CLOTTING RISK

ByAnna D. Garrett, PharmD, BCPS, CPP

January 1st 2007

CLOTS UNLIKELY TO MIGRATE AFTER 5 TO10 DAYS

ByAnna D. Garrett, PharmD, BCPS, CPP

January 1st 2007

GENERIC WARFARIN A SAFE SUBSTITUTE

ByAnna D. Garrett, PharmD, BCPS, CPP

January 1st 2007

TIPS FOR MANAGING NOSEBLEEDS

ByAnna D. Garrett, PharmD, BCPS, CPP

January 1st 2007

ASPIRIN UNDER STUDY FOR ANTICANCER EFFECTS

ByAnna D. Garrett, PharmD, BCPS, CPP

December 1st 2006

ASPIRIN AS EFFECTIVE AS ENOXAPARIN FOR PREVENTION OF RECURRENT MISCARRIAGE

ByAnna D. Garrett, PharmD, BCPS, CPP

December 1st 2006

ATRIAL FIBRILLATION GUIDELINES UPDATED

ByAnna D. Garrett, PharmD, BCPS, CPP

December 1st 2006

WARFARIN/ASPIRIN COMBINATION IN PAD INCREASES BLEEDING RISK

ByAnna D. Garrett, PharmD, BCPS, CPP

December 1st 2006

SMOKING WEAKENS ANTICLOTTING EFFECT OF ASPIRIN

ByAnna D. Garrett, PharmD, BCPS, CPP

December 1st 2006

Patients Should be Chosen Wisely for Newer Treatments

ByAnna D. Garrett, PharmD, BCPS, CPP

November 1st 2006

FDA ISSUES WARNING REGARDING BIRTH CONTROL PATCH

ByAnna D. Garrett, PharmD, BCPS, CPP

November 1st 2006

COMBINED ANTITHROMBOTIC THERAPY INCREASES RISK OF GI BLEEDING

ByAnna D. Garrett, PharmD, BCPS, CPP

November 1st 2006

NEW CASES OF AF RISING DRAMATICALLY

ByAnna D. Garrett, PharmD, BCPS, CPP

November 1st 2006

ELDERLY PEOPLE ON CHRONIC LOW-DOSE ASPIRIN LESS LIKELY TO BE ANEMIC

ByAnna D. Garrett, PharmD, BCPS, CPP

November 1st 2006

IDENTIFYING PATIENTS AT RISK FOR RECURRENT VTE

ByAnna D. Garrett, PharmD, BCPS, CPP

October 1st 2006

USE OF ASPIRIN AND IBUPROFEN

ByAnna D. Garrett, PharmD, BCPS, CPP

October 1st 2006

FIXED-DOSE HEPARIN EFFECTIVE IN VTE TREATMENT

ByAnna D. Garrett, PharmD, BCPS, CPP

October 1st 2006

RESOURCES AVAILABLE FOR PATIENTS WITH CLOTTING DISORDERS

ByAnna D. Garrett, PharmD, BCPS, CPP

October 1st 2006

TIAs: WHAT TO DO WHEN ASPIRIN IS NOT ENOUGH

ByAnna D. Garrett, PharmD, BCPS, CPP

October 1st 2006

Exercise and Diabetes: ADA Issues New Guidelines

ByAnna D. Garrett, PharmD, BCPS, CPP

September 1st 2006

AMERICAN HEART ASSOCIATION ISSUES NEW STROKE-PREVENTION GUIDELINES

ByAnna D. Garrett, PharmD, BCPS, CPP

September 1st 2006

WARFARIN THERAPY SUPERIOR TO CLOPIDOGREL/ASPIRIN IN AF

ByAnna D. Garrett, PharmD, BCPS, CPP

September 1st 2006

CRANBERRY/WARFARIN INTERACTION REVISITED

ByAnna D. Garrett, PharmD, BCPS, CPP

September 1st 2006

Anna D. Garrett, PharmD, BCPS, CPP

Articles by Anna D. Garrett, PharmD, BCPS, CPP

HEALTHY DIET MAY DECREASE RISK OF VTE

FISH OIL/WARFARIN COMBINATION MAY INCREASE BLEEDING RISK

AAICH RATE INCREASING

WARFARIN SENSITIVITY DNA TEST LAUNCHED

DOES ASPIRIN USE AFFECT ICH OUTCOME?

TEST HELPS PREDICT RISK OF RECURRENT VTE

PLAN NOW FOR DVT AWARENESS MONTH

DRUG-ELUTING STENTS MAY POSE CLOTTING RISK

CLOTS UNLIKELY TO MIGRATE AFTER 5 TO10 DAYS

GENERIC WARFARIN A SAFE SUBSTITUTE

TIPS FOR MANAGING NOSEBLEEDS

ASPIRIN UNDER STUDY FOR ANTICANCER EFFECTS

ASPIRIN AS EFFECTIVE AS ENOXAPARIN FOR PREVENTION OF RECURRENT MISCARRIAGE

ATRIAL FIBRILLATION GUIDELINES UPDATED

WARFARIN/ASPIRIN COMBINATION IN PAD INCREASES BLEEDING RISK

SMOKING WEAKENS ANTICLOTTING EFFECT OF ASPIRIN

Patients Should be Chosen Wisely for Newer Treatments

FDA ISSUES WARNING REGARDING BIRTH CONTROL PATCH

COMBINED ANTITHROMBOTIC THERAPY INCREASES RISK OF GI BLEEDING

NEW CASES OF AF RISING DRAMATICALLY

ELDERLY PEOPLE ON CHRONIC LOW-DOSE ASPIRIN LESS LIKELY TO BE ANEMIC

IDENTIFYING PATIENTS AT RISK FOR RECURRENT VTE

USE OF ASPIRIN AND IBUPROFEN

FIXED-DOSE HEPARIN EFFECTIVE IN VTE TREATMENT

RESOURCES AVAILABLE FOR PATIENTS WITH CLOTTING DISORDERS

TIAs: WHAT TO DO WHEN ASPIRIN IS NOT ENOUGH

Exercise and Diabetes: ADA Issues New Guidelines

AMERICAN HEART ASSOCIATION ISSUES NEW STROKE-PREVENTION GUIDELINES

WARFARIN THERAPY SUPERIOR TO CLOPIDOGREL/ASPIRIN IN AF

CRANBERRY/WARFARIN INTERACTION REVISITED

Trending on Pharmacy Times

A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin

MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market

Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health

Low-Dose Aspirin Linked to Lower Cardiovascular Risk in Type 2 Diabetes

Interim Phase 2 IOV-LUNG-202 Data Show Lifileucel’s Potential Treating Advanced NSCLC